BOLD — Boundless Bio, Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1782303 ·
Last close
$2.41
Market Cap
$54.16M
52W High
$2.79
52W Low
$1.12
ADV30
2,433,129
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -14,475,000 | -13,555,000 | 140,970,000 | 17,483,000 | 54,587,000 |
| Dec 2025 | 0 | — | -14,002,000 | -12,885,000 | 157,059,000 | 17,868,000 | 58,405,000 |
| Sep 2025 | 0 | — | -15,148,000 | -13,879,000 | 168,721,000 | 14,980,000 | 58,552,000 |
| Jun 2025 | 0 | — | -17,061,000 | -15,675,000 | 179,453,000 | 14,697,000 | 56,762,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-46,661,000
Investing CF
$37,801,000
Financing CF
$141,000
CapEx
$-546,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-2.61
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-259,669,000
Inventory
—
Receivables
—
ST Investments
$89,713,000
EBIT TTM
$-63,552,000
Pretax Income TTM
$-58,197,000
Interest Exp TTM
—
Analysts
1
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -63,552,000 | -58,197,000 | 157,059,000 | 58,405,000 | — | -46,661,000 |
| Dec 2024 | 0 | -73,267,000 | -65,363,000 | 206,409,000 | 55,767,000 | — | -60,841,000 |
| Dec 2023 | 0 | -54,796,000 | -49,434,000 | 129,894,000 | 256,976,000 | — | -46,855,000 |
| Dec 2022 | 0 | -46,469,000 | -45,901,000 | 76,829,000 | 158,525,000 | — | -39,596,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.93
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| MREO | Mereo BioPharma Group plc | $53.47M | $0.34 | — |
| INCR | Intercure Ltd. | $55.44M | $0.97 | — |
| FLNA | FILANA THERAPEUTICS, INC. | $57.00M | $1.18 | — |
| CLCS | Cell Source, Inc. | $58.48M | $0.86 | — |
| MCRB | Seres Therapeutics, Inc. | $59.17M | $6.11 | — |
News headlines (Yahoo Finance, 1h cache)
Why Did BOLD, BLZE, QNT Stocks Surge To 52-Week Highs Today
2026-06-24 02:53 · Yahoo
Sector Update: Healthcare Stocks Higher Late Afternoon
2026-06-23 19:46 · Yahoo
Sector Update: Healthcare Stocks Advance in Afternoon Trading
2026-06-23 17:38 · Yahoo
BOLD Stock Is Up 90% — Here's What's Behind The Biggest Rally In Company History
2026-06-23 17:32 · Yahoo
Boundless Bio and Serapha Bio Announce Merger Agreement and $230 Million Concurrent Private Placement
2026-06-23 11:30 · Yahoo
Boundless Bio Reports First Quarter 2026 Financial Results and Business Highlights
2026-05-08 11:00 · Yahoo
Boundless Bio Presents Preclinical Breast Cancer Data from its Oral Kinesin Degrader Program at 2026 AACR Annual Meeting
2026-04-17 20:49 · Yahoo
Boundless Bio Announces Upcoming Presentation of Oral Kinesin Degrader Program at the American Association for Cancer Research Annual Meeting 2026
2026-03-17 20:52 · Yahoo
Boundless Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
2026-03-09 11:00 · Yahoo
Boundless Bio to Participate in the Leerink Global Healthcare Conference
2026-03-04 12:00 · Yahoo
Recent Insider Activity
| Filed | Trade | Insider | Title | Type | Price | Qty | Value |
|---|---|---|---|---|---|---|---|
| 2026-07-08 20:06:07 | 2026-07-06 | Tang Kevin | 10% | P - Purchase | 2.48 | 57210 | 141865 |
| 2026-07-02 19:45:48 | 2026-06-30 | Tang Kevin | 10% | P - Purchase | 2.5 | 107463 | 268880 |